Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Research Area(s) / Expertise: Job title: Consultant Cardiologist
Dr Rebecca Dobson is a Consultant Cardiologist at theLiverpool Centre for Cardiovascular Science at the University of Liverpool, Liverpool Heart & Chest Hospital, in Liverpool, UK. She has a special interest in imaging and cardio-oncology. Dr Dobson's research interests include cardio-oncology, cardiac imaging and advanced echocardiography, including chemotherapy-induced left ventricular… View more
Author(s): Marielle Scherrer-Crosbie Added: 1 year ago
ACC.23/WCC — In this succinct late-breaking science interview, Investigator, Dr Marielle Scherrer-Crosbie (Hospital of the University of Pennsylvania, US) discusses the results from the STOP-CA trial (Massachusetts General Hospital). This randomized phase II trial aims to investigate whether atorvastatin, a commonly prescribed statin drug for reducing cholesterol levels, can protect the heart… View more
Author(s): Harriette Van Spall , Stefan James Added: 1 year ago
AHA 2023 — Investigator, Prof Stefan James, Prof Jonas Oldgren (Uppsala University, SE) and Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) discuss the findings of the DAPA-MI trial (NCT04564742).This multicenter, parallel-group, registry-based, randomized, double-blind and placebo-controlled phase 3 trial (AstraZeneca) investigated the effect of dapagliflozin 10 mg vs placebo… View more
Author(s): Enoch Akowuah , Annapoorna Kini , Atul Verma , et al Added: 1 year ago
Our regular review series View from the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen(Thoraxcentre, Erasmus MC, Rotterdam, NL) provides a critical analysis of the late-breaking and featured science results and spotlights impactful data. For a deeper look into the key clinical trial data revealed at ACC 23, Dr Harriette Van Spall(McMaster University, Hamilton, CA)… View more